Related Experiment Videos
Unresectable primary facial cutaneous carcinoma
1Department of Dermatology, University of Iowa Hospitals and Clinics, Iowa City 52242.
The Journal of Dermatologic Surgery and Oncology
|February 1, 1992
Summary
Nonmelanoma skin cancers have high cure rates, but some aggressive types may recur. Recurrent tumors, especially in critical areas, necessitate a multidisciplinary tumor board approach for effective management.
Area of Science:
- Oncology
- Dermatology
Background:
- Nonmelanoma skin cancers (NMSC) affect over 500,000 individuals annually in the US.
- Standard treatments report cure rates exceeding 90%.
Observation:
- Despite high cure rates, thousands of patients require secondary treatments.
- Aggressive NMSC subtypes may resist single-modality treatment, leading to recurrence.
- Recurrent tumors in critical anatomical sites pose significant management challenges.
Findings:
- Recurrent aggressive nonmelanoma skin cancers necessitate specialized, multidisciplinary care.
- Combined tumor board evaluation is advocated for complex cases.
Implications:
- A multidisciplinary approach improves outcomes for patients with recurrent NMSC.
- Early consideration of tumor board consultation can optimize treatment strategies for challenging skin cancer cases.